161 related articles for article (PubMed ID: 21283570)
1. Serological response to the 2009 pandemic influenza A (H1N1) virus for disease diagnosis and estimating the infection rate in Thai population.
Lerdsamran H; Pittayawonganon C; Pooruk P; Mungaomklang A; Iamsirithaworn S; Thongcharoen P; Kositanont U; Auewarakul P; Chokephaibulkit K; Oota S; Pongkankham W; Silaporn P; Komolsiri S; Noisumdaeng P; Chotpitayasunondh T; Sangsajja C; Wiriyarat W; Louisirirotchanakul S; Puthavathana P
PLoS One; 2011 Jan; 6(1):e16164. PubMed ID: 21283570
[TBL] [Abstract][Full Text] [Related]
2. Sensitivity and specificity of serologic assays for detection of human infection with 2009 pandemic H1N1 virus in U.S. populations.
Veguilla V; Hancock K; Schiffer J; Gargiullo P; Lu X; Aranio D; Branch A; Dong L; Holiday C; Liu F; Steward-Clark E; Sun H; Tsang B; Wang D; Whaley M; Bai Y; Cronin L; Browning P; Dababneh H; Noland H; Thomas L; Foster L; Quinn CP; Soroka SD; Katz JM
J Clin Microbiol; 2011 Jun; 49(6):2210-5. PubMed ID: 21471339
[TBL] [Abstract][Full Text] [Related]
3. Erythrocyte binding preference of human pandemic influenza virus a and its effect on antibody response detection.
Makkoch J; Prachayangprecha S; Payungporn S; Chieochansin T; Songserm T; Amonsin A; Poovorawan Y
Ann Lab Med; 2012 Jul; 32(4):276-82. PubMed ID: 22779069
[TBL] [Abstract][Full Text] [Related]
4. Serological analysis of human pandemic influenza (H1N1) in Thailand.
Prachayangprecha S; Makkoch J; Payungporn S; Chieochansin T; Vuthitanachot C; Vuthitanachot V; Theamboonlers A; Poovorawan Y
J Health Popul Nutr; 2010 Dec; 28(6):537-44. PubMed ID: 21261198
[TBL] [Abstract][Full Text] [Related]
5. Assessment of baseline age-specific antibody prevalence and incidence of infection to novel influenza A/H1N1 2009.
Hardelid P; Andrews NJ; Hoschler K; Stanford E; Baguelin M; Waight PA; Zambon M; Miller E
Health Technol Assess; 2010 Dec; 14(55):115-92. PubMed ID: 21208549
[TBL] [Abstract][Full Text] [Related]
6. Cumulative incidence of pandemic influenza A (H1N1) 2009 by a community-based serological cohort study in Selenghe Province, Mongolia.
Burmaa A; Tsatsral S; Odagiri T; Suzuki A; Oshitani H; Nymadawa P
Influenza Other Respir Viruses; 2012 Nov; 6(6):e97-e104. PubMed ID: 22329794
[TBL] [Abstract][Full Text] [Related]
7. Rate of decline of antibody titers to pandemic influenza A (H1N1-2009) by hemagglutination inhibition and virus microneutralization assays in a cohort of seroconverting adults in Singapore.
Hsu JP; Zhao X; Chen MI; Cook AR; Lee V; Lim WY; Tan L; Barr IG; Jiang L; Tan CL; Phoon MC; Cui L; Lin R; Leo YS; Chow VT
BMC Infect Dis; 2014 Jul; 14():414. PubMed ID: 25066592
[TBL] [Abstract][Full Text] [Related]
8. Poor immune response to a standard single dose non-adjuvanted vaccination against 2009 pandemic H1N1 influenza virus A in the adult and elder hemodialysis patients.
Chang YT; Guo CY; Tsai MS; Cheng YY; Lin MT; Chen CH; Shen D; Wang JR; Sung JM
Vaccine; 2012 Jul; 30(33):5009-18. PubMed ID: 22658967
[TBL] [Abstract][Full Text] [Related]
9. Serological evidence of subclinical transmission of the 2009 pandemic H1N1 influenza virus outside of Mexico.
Chao DY; Cheng KF; Li TC; Wu TN; Chen CY; Tsai CA; Chen JH; Chiu HT; Lu JJ; Su MC; Liao YH; Chan WC; Hsieh YH
PLoS One; 2011 Jan; 6(1):e14555. PubMed ID: 21267441
[TBL] [Abstract][Full Text] [Related]
10. Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.
Maruszak H; Jeganathan S; Smith DE; Robertson P; Barnes T; Furner V
HIV Med; 2012 Jul; 13(6):352-7. PubMed ID: 22296264
[TBL] [Abstract][Full Text] [Related]
11. Immune protection induced on day 10 following administration of the 2009 A/H1N1 pandemic influenza vaccine.
Sun Y; Bian C; Xu K; Hu W; Wang T; Cui J; Wu H; Ling Z; Ji Y; Lin G; Tian L; Zhou Y; Li B; Hu G; Yu N; An W; Pan R; Zhou P; Leng Q; Huang Z; Ma X; Sun B
PLoS One; 2010 Dec; 5(12):e14270. PubMed ID: 21151563
[TBL] [Abstract][Full Text] [Related]
12. A Large Proportion of the Mexican Population Remained Susceptible to A(H1N1)pdm09 Infection One Year after the Emergence of 2009 Influenza Pandemic.
Veguilla V; López-Gatell H; López-Martínez I; Aparicio-Antonio R; Barrera-Badillo G; Rojo-Medina J; Gross FL; Jefferson SN; Katz JM; Hernández-Ávila M; Alpuche-Aranda CM
PLoS One; 2016; 11(3):e0150428. PubMed ID: 27003409
[TBL] [Abstract][Full Text] [Related]
13. Differences in antibody responses of individuals with natural infection and those vaccinated against pandemic H1N1 2009 influenza.
Chan KH; To KK; Hung IF; Zhang AJ; Chan JF; Cheng VC; Tse H; Che XY; Chen H; Yuen KY
Clin Vaccine Immunol; 2011 May; 18(5):867-73. PubMed ID: 21411604
[TBL] [Abstract][Full Text] [Related]
14. Determination of antibody response to the human pandemic influenza H1N1 2009 among patients with influenza-like illness and high risk groups.
Makkoch J; Payungporn S; Prachayangprecha S; Tantilertcharoen R; Poovorawan Y
Asian Pac J Allergy Immunol; 2010 Mar; 28(1):67-75. PubMed ID: 20527519
[TBL] [Abstract][Full Text] [Related]
15. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study.
Miller E; Hoschler K; Hardelid P; Stanford E; Andrews N; Zambon M
Lancet; 2010 Mar; 375(9720):1100-8. PubMed ID: 20096450
[TBL] [Abstract][Full Text] [Related]
16. Seasonal H1N1 2007 influenza virus infection is associated with elevated pre-exposure antibody titers to the 2009 pandemic influenza A (H1N1) virus.
Lemaitre M; Leruez-Ville M; De Lamballerie XN; Salez N; Garrone P; Fluckiger AC; Klatzmann D; Carrat F
Clin Microbiol Infect; 2011 May; 17(5):732-7. PubMed ID: 20731679
[TBL] [Abstract][Full Text] [Related]
17. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
[TBL] [Abstract][Full Text] [Related]
18. Association between Hemagglutinin Stem-Reactive Antibodies and Influenza A/H1N1 Virus Infection during the 2009 Pandemic.
Hoa LNM; Mai LQ; Bryant JE; Thai PQ; Hang NLK; Yen NTT; Duong TN; Thoang DD; Horby P; Werheim HFL; Fox A
J Virol; 2016 Jul; 90(14):6549-6556. PubMed ID: 27170747
[TBL] [Abstract][Full Text] [Related]
19. Post-pandemic seroprevalence of pandemic influenza A (H1N1) 2009 infection (swine flu) among children <18 years in Germany.
von Kries R; Weiss S; Falkenhorst G; Wirth S; Kaiser P; Huppertz HI; Tenenbaum T; Schroten H; Streng A; Liese J; Shai S; Niehues T; Girschick H; Kuscher E; Sauerbrey A; Peters J; Wirsing von König CH; Rückinger S; Hampl W; Michel D; Mertens T
PLoS One; 2011; 6(9):e23955. PubMed ID: 21915270
[TBL] [Abstract][Full Text] [Related]
20. Estimating age-specific cumulative incidence for the 2009 influenza pandemic: a meta-analysis of A(H1N1)pdm09 serological studies from 19 countries.
Van Kerkhove MD; Hirve S; Koukounari A; Mounts AW;
Influenza Other Respir Viruses; 2013 Sep; 7(5):872-86. PubMed ID: 23331969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
